Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾Ï¿¡¼­ MIB1 (Ki-67) Labeling Index ¿¬±¸¿Í ´Ù¸¥ ¿¹ÈÄÀÎÀÚµé°úÀÇ ¿¬°ü¼º ºñ±³ Assessment of MIB1 (Ki-67) Labeling Index and Correlation with Other Well Established Prognostic Factors in Breast Cancer

´ëÇÑ¿Ü°úÇÐȸÁö 2001³â 60±Ç 4È£ p.361 ~ 367
°íâ´ë, ¿À½Â±Ù, ÃÖ±¹Áø, À±¿©±Ô, ³ëµ¿¿µ, ±è¼º¿ø, °­ÈñÁØ,
¼Ò¼Ó »ó¼¼Á¤º¸
°íâ´ë ( Ko Chang-Dae ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

¿À½Â±Ù ( Oh Seung-Keun ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÃÖ±¹Áø ( Choi Kook-Jin ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
À±¿©±Ô ( Youn Yeo-Kyu ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
³ëµ¿¿µ ( Roh Dong-Young ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±è¼º¿ø ( Kim Sung-Won ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
°­ÈñÁØ ( Kang Hee-Joon ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose: The MIB1 labeling index is new method utilizing a monoclonal antibody against Ki-67 antigen and useful for evaluating the proliferation rate in breast cancer due to its ease of use and reliability. We compared the MIB1 labeling index to other, well established prognostic factors and assessed the prognostic value of MIB1 in 564 breast cancers.

Methods: The MIB1 (Ki-67 equivalent monoclonal antibody) proliferation rate, MIB1 labeling index, was determined in formalin-fixed, paraffin-embedded tissue specimens of 564 primary breast cancer patients who underwent surgery between March 1998 and February 2000 at Seoul National University Hospital. The clinicopathologic characteristics of the primary tumor such as age, tumor size, histologic type, nuclear grade, histologic grade, hormone receptor status and various tumor markers (p53, c-erbB-2, bcl-2) were compared with the value of the MIB1 labeling Index.

Results: The mean value of MIB1 labeling index was 6.9. MIB1 labeling index was correlated to younger age (p= 0.011), histologic types, low nuclear grade (p=0.0001), high histologic grade (p=0.0001), p53 positive (IDC) (p=0.0001), c-erbB-2 positive (DCIS) (p=0.01), comedo type (DCIS) (p= 0.001) and inversely correlated to hormone receptor positivity (p=0.0001), bcl-2 positive (IDC) (p=0.001). No correlation was found in tumor size, lymph node status and c-erbB-2 positive (IDC).

Conclusion: The MIB1 labeling index correlated well with well-established poor prognostic factors. The MIB1 labeling index may be an important prognostic determinant in breast cancer.

Å°¿öµå

MIB1;Ki-67;À¯¹æ¾Ï;°ü»óÇdz»¾Ï;ħÀ±¼º°ü¾Ï
MIB1;Ki-67;Breast cancer;Ductal carcinoma in situ (DCIS);Invasive ductal carcinoma (IDC)

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS